New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment
Authors
Keywords
-
Journal
Nanomedicine
Volume 15, Issue 29, Pages 2819-2821
Publisher
Future Medicine Ltd
Online
2020-12-03
DOI
10.2217/nnm-2020-0371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can melatonin reduce the severity of COVID-19 pandemic?
- (2020) Alex Shneider et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Melatonin: Roles in influenza, Covid‐19, and other viral infections
- (2020) George Anderson et al. REVIEWS IN MEDICAL VIROLOGY
- Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
- (2020) Alejandro Romero et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment
- (2020) Virna Margarita Martín Giménez et al. LIFE SCIENCES
- COVID-19: Melatonin as a potential adjuvant treatment
- (2020) Rui Zhang et al. LIFE SCIENCES
- Mitochondria-Inspired Nanoparticles with Microenvironment-Adapting Capacities for On-Demand Drug Delivery after Ischemic Injury
- (2020) Yanxia Lin et al. ACS Nano
- Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19
- (2020) Mohamed A. El-Missiry et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis
- (2020) Suvojit Hazra et al. LIFE SCIENCES
- NANOTECHNOLOGICAL STRATEGIES AS SMART WAYS FOR DIAGNOSIS AND TREATMENT OF THE ATHEROSCLEROSIS
- (2019) Virna Mart et al. CURRENT PHARMACEUTICAL DESIGN
- Current drug nano-targeting strategies for improvement in the diagnosis and treatment of prevalent pathologies such as cardiovascular and renal diseases
- (2019) Virna Margarita Martín Giménez et al. CURRENT DRUG TARGETS
- Melatonin Loading Chitosan-Tripolyphosphate Nanoparticles: Application in Attenuating Etoposide-Induced Genotoxicity in HepG2 Cells
- (2018) Mohammad Shokrzadeh et al. PHARMACOLOGY
- Poly(Lactide-Co-Glycolide)-Monomethoxy-Poly-(Polyethylene Glycol) Nanoparticles Loaded with Melatonin Protect Adipose-Derived Stem Cells Transplanted in Infarcted Heart Tissue
- (2018) Qiang Ma et al. STEM CELLS
- Preparation and characterization of bosentan monohydrate/ε‐polycaprolactone nanoparticles obtained by electrospraying
- (2018) Virna M. Giménez et al. BIOTECHNOLOGY PROGRESS
- Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice
- (2015) José A. García et al. FASEB JOURNAL
- Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit
- (2015) Antonio Leonardi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started